The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System

被引:11
作者
Liu, Xiangqian [1 ,2 ]
Vigorito, Michael [1 ,3 ]
Huang, Wenfei [1 ,4 ]
Khan, Mohammed A. S. [5 ,6 ]
Chang, Sulie L. [1 ,4 ]
机构
[1] Inst Neuroimmune Pharmacol, Seton Hall Univ, S Orange, NJ 07079 USA
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Histol & Embryol, Wuhan 430030, Peoples R China
[3] Seton Hall Univ, Dept Psychol, S Orange, NJ 07079 USA
[4] Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA
[6] Shriners Hosp Children, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
Microbiota; Neuroinflammation; Alzheimer's disease; Parkinson's disease; Addiction; QIAGEN Ingenuity Pathway Analysis; ACUTE BINGE DRINKING; GUT-BRAIN AXIS; PARKINSONS-DISEASE; SPECTRUM DISORDERS; INTESTINAL BARRIER; ORAL MICROBIOTA; GENE-EXPRESSION; IMMUNE-SYSTEM; HUMAN HEALTH; HPA AXIS;
D O I
10.1007/s11481-021-10033-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The human digestive tract contains a diverse and abundant microbiota that is important for health. Excessive alcohol use can disrupt the balance of these microbes (known as dysbiosis), leading to elevated blood endotoxin levels and systemic inflammation. Using QIAGEN Ingenuity Pathway Analysis (IPA) bioinformatics tool, we have confirmed that peripheral endotoxin (lipopolysaccharide) mediates various cytokines to enhance the neuroinflammation signaling pathway. The literature has identified alcohol-mediated neuroinflammation as a possible risk factor for the onset and progression of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), and psychiatric disorders such as addiction to alcohol and other drugs. In this review, we discuss alcohol-use-induced dysbiosis in the gut and other body parts as a causal factor in the progression of Central Nervous System (CNS) diseases including neurodegenerative disease and possibly alcohol use disorder.
引用
收藏
页码:131 / 151
页数:21
相关论文
共 50 条
  • [21] Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges
    Kamat, Chandrashekhar D.
    Gadal, Sunyana
    Mhatre, Molina
    Williamson, Kelly S.
    Pye, Quentin N.
    Hensley, Kenneth
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (03) : 473 - 493
  • [22] NLRP3 inflammasome in neuroinflammation and central nervous system diseases
    Xu, Wen
    Huang, Yi
    Zhou, Rongbin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2025, 22 (04) : 341 - 355
  • [23] Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases
    Lan, Ting
    Sun, Ting Ting
    Wei, Chao
    Cheng, Tian
    Yang, Fei
    Zhang, Jian-Nan
    Li, Qian
    MOLECULAR NEUROBIOLOGY, 2023, 60 (07) : 3584 - 3599
  • [24] PPARγ as a therapeutic target in central nervous system diseases
    Sundararajan, Sophia
    Jiang, Qingguang
    Heneka, Michael
    Landreth, Gary
    NEUROCHEMISTRY INTERNATIONAL, 2006, 49 (02) : 136 - 144
  • [25] Targeting protein kinases in central nervous system disorders
    Chico, Laura K.
    Van Eldik, Linda J.
    Watterson, D. Martin
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (11) : 892 - 909
  • [26] CELL TRANSPLANTATION FOR CENTRAL-NERVOUS-SYSTEM DISORDERS
    KOUTOUZIS, TK
    EMERICH, DF
    BORLONGAN, CV
    FREEMAN, TB
    CAHILL, DW
    SANBERG, PR
    CRITICAL REVIEWS IN NEUROBIOLOGY, 1994, 8 (03): : 125 - 162
  • [27] Extracellular vesicles for the treatment of central nervous system diseases
    Gratpain, Viridiane
    Mwema, Ariane
    Labrak, Yasmine
    Muccioli, Giulio G.
    van Pesch, Vincent
    des Rieux, Anne
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 174 (174) : 535 - 552
  • [28] Research progress on adenosine in central nervous system diseases
    Liu, Ying-Jiao
    Chen, Jiao
    Li, Xun
    Zhou, Xin
    Hu, Yao-Mei
    Chu, Shi-Feng
    Peng, Ye
    Chen, Nai-Hong
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (09) : 899 - 910
  • [29] Cell encapsulation for the treatment of central nervous system disorders
    Portero, Aitziber
    Orive, Gorka
    Hernandez, Rosa M.
    Luis Pedraz, Jose
    REVISTA DE NEUROLOGIA, 2010, 50 (07) : 409 - 419
  • [30] Lactylation and Central Nervous System Diseases
    Chen, Ye
    Xiao, Dongqiong
    Li, Xihong
    BRAIN SCIENCES, 2025, 15 (03)